Literature DB >> 18400759

Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice.

Adam L Orr1, Shanshan Huang, Meredith A Roberts, John C Reed, Shihua Li, Xiao-Jiang Li.   

Abstract

The pathogenesis of Huntington disease (HD) is attributed to the misfolding of huntingtin (htt) caused by an expanded polyglutamine (polyQ) domain. Considerable effort has been devoted to identifying molecules that can prevent or reduce htt misfolding and the associated neuropathology. Although overexpression of chaperones is known to reduce htt cytotoxicity in cellular models, only modest protection is seen with Hsp70 overexpression in HD mouse models. Because the activity of Hsp70 is modulated by co-chaperones, an interesting issue is whether the in vivo effects of chaperones on polyQ protein toxicity are dependent on other modulators. In the present study, we focused on BAG1, a co-chaperone that interacts with Hsp70 and regulates its activity. Of htt mice expressing the N171-82Q mutant, we found that male N171-82Q mice show a greater deficit in rotarod performance than female N171-82Q mice. This sex-dependent motor deficit was improved by crossing N171-82Q mice with transgenic mice overexpressing BAG1 in neurons. Transgenic BAG1 also reduces the levels of mutant htt in synaptosomal fraction of male HD mice. Overexpression of BAG1 augmented the effects of Hsp70 by reducing aggregation of mutant htt in cultured cells and improving neurite outgrowth in htt-transfected PC12 cells. These findings suggest that the effects of chaperones on HD pathology are influenced by both their modulators and sex-dependent factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400759      PMCID: PMC2414304          DOI: 10.1074/jbc.M710606200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Regulation of intracellular trafficking of huntingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth.

Authors:  Juan Rong; John R McGuire; Zhi-Hui Fang; Guoqing Sheng; Ji-Yeon Shin; Shi-Hua Li; Xiao-Jiang Li
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

2.  CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation.

Authors:  Ismael Al-Ramahi; Yung C Lam; Hung-Kai Chen; Beatrice de Gouyon; Minghang Zhang; Alma M Pérez; Joana Branco; Maria de Haro; Cam Patterson; Huda Y Zoghbi; Juan Botas
Journal:  J Biol Chem       Date:  2006-07-10       Impact factor: 5.157

3.  Interaction of BAG1 and Hsp70 mediates neuroprotectivity and increases chaperone activity.

Authors:  Jan Liman; Sundar Ganesan; Christoph P Dohm; Stan Krajewski; John C Reed; Mathias Bähr; Fred S Wouters; Pawel Kermer
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

4.  Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

Authors:  Patrick Weydt; Victor V Pineda; Anne E Torrence; Randell T Libby; Terrence F Satterfield; Eduardo R Lazarowski; Merle L Gilbert; Gregory J Morton; Theodor K Bammler; Andrew D Strand; Libin Cui; Richard P Beyer; Courtney N Easley; Annette C Smith; Dimitri Krainc; Serge Luquet; Ian R Sweet; Michael W Schwartz; Albert R La Spada
Journal:  Cell Metab       Date:  2006-10-19       Impact factor: 27.287

5.  Sexual dimorphism of the intracellular heat shock protein 72 response.

Authors:  M Nickerson; S L Kennedy; J D Johnson; M Fleshner
Journal:  J Appl Physiol (1985)       Date:  2006-05-11

6.  Sex differences in heat shock protein 72 expression and localization in rats following renal ischemia-reperfusion injury.

Authors:  Andrea Fekete; Adám Vannay; Agota Vér; Krisztina Rusai; Veronika Müller; György Reusz; Tivadar Tulassay; Attila J Szabó
Journal:  Am J Physiol Renal Physiol       Date:  2006-04-11

Review 7.  Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.

Authors:  H Adachi; M Waza; M Katsuno; F Tanaka; M Doyu; G Sobue
Journal:  Neuropathol Appl Neurobiol       Date:  2007-04       Impact factor: 8.090

8.  Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.

Authors:  Jenelle L Dorner; Benjamin R Miller; Scott J Barton; Tyler J Brock; George V Rebec
Journal:  Behav Brain Res       Date:  2007-01-18       Impact factor: 3.332

9.  Exercise training improves myocardial tolerance to ischemia in male but not in female rats.

Authors:  David B Thorp; James V Haist; Jennifer Leppard; Kevin J Milne; Morris Karmazyn; Earl G Noble
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-05-16       Impact factor: 3.619

10.  Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease.

Authors:  Coralie Vacher; Lourdes Garcia-Oroz; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2005-10-04       Impact factor: 6.150

View more
  11 in total

1.  Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor.

Authors:  Shanshan Huang; Joseph J Ling; Su Yang; Xiao-Jiang Li; Shihua Li
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

2.  Automated imaging system for fast quantitation of neurons, cell morphology and neurite morphometry in vivo and in vitro.

Authors:  Victor Tapias; J Timothy Greenamyre; Simon C Watkins
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

3.  Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease.

Authors:  Nigel I Wood; Valentina Carta; Stefan Milde; Elizabeth A Skillings; Catherine J McAllister; Y L Mabel Ang; Alasdair Duguid; Nadeev Wijesuriya; Samira Mohd Afzal; Joe X Fernandes; T W Leong; A Jennifer Morton; Jennifer Morton
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

4.  Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems.

Authors:  Haiqun Jia; Ryan J Kast; Joan S Steffan; Elizabeth A Thomas
Journal:  Hum Mol Genet       Date:  2012-09-10       Impact factor: 6.150

5.  Activation of gene transcription by heat shock protein 27 may contribute to its neuronal protection.

Authors:  Meyer J Friedman; Shihua Li; Xiao-Jiang Li
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

6.  Deletion of the huntingtin proline-rich region does not significantly affect normal huntingtin function in mice.

Authors:  Michelle Neveklovska; Erin B D Clabough; Joan S Steffan; Scott O Zeitlin
Journal:  J Huntingtons Dis       Date:  2012

Review 7.  Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.

Authors:  Pawel M Switonski; Wojciech J Szlachcic; Agnieszka Gabka; Wlodzimierz J Krzyzosiak; Maciej Figiel
Journal:  Mol Neurobiol       Date:  2012-09-04       Impact factor: 5.590

8.  Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment.

Authors:  Peggy C Nopoulos; Elizabeth H Aylward; Christopher A Ross; James A Mills; Douglas R Langbehn; Hans J Johnson; Vincent A Magnotta; Ronald K Pierson; Leigh J Beglinger; Martha A Nance; Roger A Barker; Jane S Paulsen
Journal:  Brain       Date:  2010-10-04       Impact factor: 13.501

9.  Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactions.

Authors:  Adam Sharp; Simon J Crabb; Peter W M Johnson; Angela Hague; Ramsey Cutress; Paul A Townsend; A Ganesan; Graham Packham
Journal:  J Pharmacol Exp Ther       Date:  2009-08-18       Impact factor: 4.030

10.  XJB-5-131-mediated improvement in physiology and behaviour of the R6/2 mouse model of Huntington's disease is age- and sex- dependent.

Authors:  Aris A Polyzos; Nigel I Wood; Paul Williams; Peter Wipf; A Jennifer Morton; Cynthia T McMurray
Journal:  PLoS One       Date:  2018-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.